These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2302011)

  • 21. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia.
    Tsatsralt-Od B; Takahashi M; Nishizawa T; Inoue J; Ulaankhuu D; Okamoto H
    Arch Virol; 2005 Dec; 150(12):2513-28. PubMed ID: 16012782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Epidemiologic study of infection with hepatitis B virus and delta agent in Sardinia. The HBV-Sardinia Research Group].
    Recenti Prog Med; 1986 Sep; 77(9):401-4. PubMed ID: 3797790
    [No Abstract]   [Full Text] [Related]  

  • 23. High prevalence of hepatitis delta virus infection detectable by enzyme immunoassay among apparently healthy individuals in Mongolia.
    Inoue J; Takahashi M; Nishizawa T; Narantuya L; Sakuma M; Kagawa Y; Shimosegawa T; Okamoto H
    J Med Virol; 2005 Jul; 76(3):333-40. PubMed ID: 15902700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis delta virus infection in Taiwan.
    Liaw YF; Lin HH; Chu CM; Sheen IS; Huang MJ
    Prog Clin Biol Res; 1987; 234():479-83. PubMed ID: 3628418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serological markers for hepatitis B virus and delta antibody in Brazilian male homosexuals].
    Ferraz ML; Vilela MP; Silva AE; Paiva ER
    Rev Paul Med; 1985; 103(5):228-30. PubMed ID: 3832313
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevalence of delta antibodies among urban HBsAg-positive chronic liver disease patients in Egypt.
    el Zayadi A; Ponzetto A; Selim O; Forzani B; Lavarini C; Rizzetto M
    Hepatogastroenterology; 1988 Dec; 35(6):313-5. PubMed ID: 3265126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Follow-up study of delta agent infection in children with chronic hepatitis B].
    Ruiz Moreno M; Camps Rubiol T; Carreño García V; Bas Pérez C; García Aguado J
    An Esp Pediatr; 1989 Apr; 30(4):255-60. PubMed ID: 2742234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroepidemiology of hepatitis B and D virus infection among intravenous drug addicts in Israel.
    Dan M; Rock M; Lilos P; Shany SB
    Int J Epidemiol; 1993 Feb; 22(1):140-3. PubMed ID: 8449634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody to hepatitis D virus (delta agent) in selected Manitoba residents, 1974-1986.
    Hannan C; Sekla L; Schacter B; Stackiw W
    Clin Invest Med; 1988 Jun; 11(3):209-12. PubMed ID: 3135966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serological markers of selected viral infections transmitted by parenteral route in drug addicts].
    Halota W; Opoka J; Trzciński J; Dorau M; Topczewska E; Giziński W; Bulik F
    Przegl Epidemiol; 1991; 45(4):347-9. PubMed ID: 1668703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study).
    Diop-Ndiaye H; Touré-Kane C; Etard JF; Lô G; Diaw P; Ngom-Gueye NF; Gueye PM; Ba-Fall K; Ndiaye I; Sow PS; Delaporte E; Mboup S
    J Med Virol; 2008 Aug; 80(8):1332-6. PubMed ID: 18551596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum anti-HD in patients with high prevalences of HBV infection.
    Doris R; Cadrobbi P; Aneloni V; Zorzi D; Pornaro E
    Prog Clin Biol Res; 1987; 234():393. PubMed ID: 3628395
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevalence of antibody to delta antigen among HBV carriers in Japan.
    Tamura I; Ichimura H; Itoh Y; Kurimura O; Kurimura T
    J Med Virol; 1987 Jul; 22(3):217-21. PubMed ID: 3625172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
    Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
    J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B and D virus infection among drug abusers in Taiwan.
    Lee SD; Wang JY; Wu JC; Chiang YT; Tsai YT; Lo KJ
    J Med Virol; 1986 Nov; 20(3):247-52. PubMed ID: 3783132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of anti-delta antibodies in pregnant women in Bandung, Indonesia.
    Vranckx R; Reniers J; Alisjahbana A; Ngantung W; Sugita E; Meheus A
    Trop Geogr Med; 1988 Jan; 40(1):17-9. PubMed ID: 3381311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Epidemiology of hepatitis D virus infection].
    Joller-Jemelka HI; Guggi T; Grob PJ
    Schweiz Med Wochenschr; 1985 Nov; 115(47):1679-84. PubMed ID: 4081699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Introduction of hepatitis delta virus into Polish drug community.
    Laskus T; Radkowski M; Lupa E; Cianciara J; Slusarczyk J; Halama G; Horban A
    Infection; 1992; 20(1):43-4. PubMed ID: 1563812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and epidemiological significance of hepatitis delta virus (HDV) infection in chronic HBV carriers in Portugal.
    Ramalho F; Carvalho G; Bonino F; Baptista A; de Moura MC
    Prog Clin Biol Res; 1987; 234():409-17. PubMed ID: 3628400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis delta virus infection: a recently imported disease in New Zealand.
    Ramirez AM; Lee SP; Woodfield DG
    N Z Med J; 1987 Apr; 100(822):235-7. PubMed ID: 3454892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.